Regulatory uncertainty prompts Chinese firms to rethink listing plans
A recent report suggests China’s regulatory clampdown is impacting listings and take-private deals.
November 02, 2021
Once a badge of honour among Chinese companies, a US listing was regarded as the alpha and omega for any Chinese corporation, offering greater control for its founders, better range of motion in mergers and acquisitions and above all prestige.
Registered users get 2 free articles in 30 days.
Subscribers have full unlimited access to FinanceAsia.
Not signed up? New users get 2 free articles per month, plus a 7-day unlimited free trial.
Questions?
See here for more information on licences and prices, or contact [email protected].